Centre hospitalier universitaire de St Etienne

Saint-Etienne 42270

0 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease, Urinary Bladder Neoplasms

Studies at this site

• A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder — Running, not enrolling
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling